Location: Naarden, Netherlands
CIK: 0002013410 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value: $414M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 10,935,310 | $224M | 54.1% | $9.56 | +132.4% | ORDINARY SHARES | N62509109 |
| DYN | DYNE THERAPEUTICS INC | 5,462,846 | $57.14M | 13.8% | $12.58 | +13.8% | COM | 26818M108 |
| ENGN | ENGENE HOLDINGS INC | 9,632,561 | $43.15M | 10.4% | $10.14 | -38.7% | COM | 29286M105 |
| REPL | REPLIMUNE GROUP INC | 3,909,696 | $38.12M | 9.2% | $11.59 | +6.7% | COM | 76029N106 |
| BCYC | BICYCLE THERAPEUTICS PLC | 3,452,330 | $29.31M | 7.1% | $18.38 | — | SPONSORED ADS | 088786108 |
| — | ASTRIA THERAPEUTICS INC | 3,822,537 | $20.41M | 4.9% | $8.05 | — | COM | 04635X102 |
| ENGNW | ENGENE HOLDINGS INC | 2,878,148 | $1.728M | 0.4% | $0.63 | — | W EXP 10/31/2028 | 29286M113 |